Reproductive Health

Perrigo Receives FDA Approval for Opill Over-the-Counter Oral Contraceptive

Perrigo has achieved a major milestone in women’s healthcare with the FDA approving Opill as an over-the-counter oral contraceptive. Opill is the first birth control pill available without a prescription in the US, revolutionizing access to contraception. Perrigo’s commitment to enhancing lives is evident in this impactful solution for women’s health. Opill has a long history of safe and effective use, supported…

Pharma Company Fresenius Kabi Launches Generic Fertility Treatment

Pharma company Fresenius Kabi has announced the launch of Ganirelix Acetate Injection, a generic fertility drug. The medication is now available for immediate purchase from Fresenius Kabi in the form of 250 mcg/0.5 mL prefilled syringes. Ganirelix Acetate Injection is primarily used to inhibit premature surges in luteinizing hormone (LH), a chemical that triggers reproductive processes like ovulation. It is specifically designed…

Proov’s Confirm PdG Ovulation Test Becomes First Third Party Women’s Health Test Available Through Questhealth.com

Quest Diagnostics and Proov have teamed up to introduce the company’s Confirm PdG test, an FDA-cleared PdG (progesterone metabolite) home test kit that confirms successful ovulation, through Questhealth.com. To date Questhealth.com has primarily offered laboratory test services provided by Quest Diagnostics. This collaboration marks the first time a women’s health test from a third-party manufacturer is available on the platform. Progesterone is…

Mark Cuban Cost Plus Drug Company Teams Up with Male Fertility Company Posterity Health

Mark Cuban’s Cost Plus Drug Company, PBC (Cost Plus Drugs) has announced a partnership with Posterity Health, a male fertility and sexual health company. Goal of this partnership is to broaden access to specialized treatment for male (in)fertility, sexual dysfunction, and low testosterone by making it more affordable. The new collaboration between addresses a notable health concern: currently, one in six couples…

INVO Bioscience’s INVOcell Device Receives FDA Approval for 5-Day Incubation in Fertility Treatment

Fertility company INVO Bioscience has received FDA clearance to expand the use of its INVOcell device, paving the way for improved patient outcomes in infertility treatment. The device, known for its affordability and effectiveness, can now be utilized for a 5-day incubation period, similar to conventional in vitro fertilization (IVF) procedures. Steve Shum, CEO of INVO Bioscience, shares: “This is a momentous…

Kindbody Adds In-House Genetic Testing with the Launch of Kindlabs

Fertility clinic network Kindbody is announcing the addition of Kindlabs, a new division to conduct in-house genetic testing, expanding Kindbody’s range of comprehensive services to offer seamless, end-to-end care. The Kindlabs launch follows last year’s acquisition of Phosphorus Labs, a preventative genomics company. Kindlabs will operate from its state-of-the-art 8,000 square foot laboratory located in Secaucus, New Jersey. It’s headed by Dr.…

UK-Based Fertility Benefits Startup Fertifa Adds £5M in Seed Funding

Fertifa, a London-based startup, helping European businesses to provide fertility and reproductive health benefits to employees has recently raised £5M in funding from Notion Capital and Triple Point Ventures. The round also saw participation from Conviction, Calm/Storm, Tiny.vc, EQT Foundation and a host of angel investors, along with the return of existing investors. Launched in 2019 by Tony Chen and Nick Kuan,…

Celmatix Advances Its Oral Fertility Drug Program in a Promising Step Towards Needle-Free IVF

Celmatix, a biotech firm specializing in women’s health, has announced progress in their oral fertility drug program. The program’s primary objective is to substitute follicle stimulating hormone (FSH) injections, commonly used in in vitro fertilization (IVF) and egg freezing protocols, with an oral alternative. This New York-based company aims to make ovulation induction more efficient, specifically for women with conditions like polycystic…